Psma Pet News Today

Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.

University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.”

PURPOSE: This study aimed to determine the viability of focal dose escalation to prostate cancer intraprostatic lesions (IPLs) from multiparametric magnetic resonance (mpMRI) and prostate-specific membrane antigen positron emission tomography (PSMA-PET) images using high-dose-rate (HDR) prostate brachytherapy (pBT). METHODS AND MATERIALS: Retrospective data from 20 patients treated with HDR pBT was utilized. The interobserver contouring variability of 5 observers was quantified using the dice si...

MyJournals.org - Science - Redefining 18F DCFPyl PSMA‐PET detected local recurrence from radical prostatectomy histopathology (BJU International)

Expert oncologists provide a focused review on goals of therapy for patients with non-metastatic castration-resistant prostate cancer (nmCRPC).

Researchers from Germany found that even in intensively pretreated prostate cancer patients single-fraction, PSMA-PET- and mpMRI-guided focal stereotactic body radiotherapy was found to be safe,...

MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces...